Previous studies show that CFIm25 inhibits the invasion and metastasis of hepatocellular carcinoma by blocking the JNK/c-Jun signaling pathway and influencing the activity of AP-1 in vitro, and we verified this result in vivo. Here, JUN is linked to hepatocellular carcinoma.